Skip to content

Artificial Intelligence-assissted Glaucoma Evaluation

Development of Artificial Intelligence-assissted Diagnostic Program of Glaucoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03268031
Acronym
AGE
Enrollment
10800
Registered
2017-08-31
Start date
2017-08-15
Completion date
2020-02-01
Last updated
2020-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Glaucoma

Keywords

artificial intelligence, glaucoma

Brief summary

Glaucoma is currently the second leading cause of irreversible blindness in the world. Our study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to create programs that can screen and diagnose glaucoma.

Detailed description

Glaucoma is currently the second leading cause of irreversible blindness in the world, which brings heavy burden to human society. Compared to other ocular diseases, diagnostic process of glaucoma is complicated depends on multiple test results, including visual field test, OCT, etc. How to diagnose glaucoma correctly and fast has always been a hot topic in glaucoma researches. Artificial intelligence is used to study and develop theories and methods that can help simulate and extend human intelligence, which has been utilized in a lot of research fields such as automatic drive and medicine. The study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to create programs that can screen and diagnose glaucoma.

Interventions

DIAGNOSTIC_TESTVisual field and OCT tests

Visual field test and OCT are commonly used essential tests to make accurate diagnosis of glaucoma. Algorithms to classify Visual field and OCT tests would both be developed and verified.

Sponsors

Chinese Academy of Sciences
CollaboratorOTHER_GOV
Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. BCVA\>0.1 2. able to complete reliable visual field test 3. no history of intraocular surgery or fundus laser

Exclusion criteria

1\. unable to complete visual field test

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of diagnosis by artificial intelligence algorithmfrom August 2017 to February 2021Accuracy of diagnosis by artificial intelligence algorithm and compare this result with glaucoma specialists

Secondary

MeasureTime frameDescription
Sensitivity of diagnosis by artificial intelligence algorithmfrom August 2017 to February 2021Sensitivity of diagnosis by artificial intelligence algorithm
Specificity of diagnosis by artificial intelligence algorithmfrom August 2017 to February 2021Specificity of diagnosis by artificial intelligence algorithm

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026